AzTrials
AzTrials

Isolated Premolar Edentulous SiteETPEI-RCTNCT03001752

Immediate Implants Inserted Through Open Flap, Open Flap and Bone Grafting and Flapless Techniques

A study testing Open flap immediate implant, Open flap immediate implant and bone grafting and Flapless immediate implant in people with Isolated Premolar Edentulous Site, run by University of Bari.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This is a three-armed randomized controlled clinical trial aiming the estimation of dimensional alveolar bone changes after insertion of post-extraction implants through 3 different surgical techniques: open flap, open flap and grafting, flapless. Read more about this study

Who is it for?
Ages 20 to 70 yearsHealthy volunteers can take part
Conditions the study is for
Isolated Premolar Edentulous Site
What is being tested?
Open flap immediate implant, Open flap immediate implant and bone grafting and Flapless immediate implant
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
45 participants
Where
No sites listed yet
Study dates
Jan 2017to Nov 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • absence of any systemic disease that might compromise implant integration or wound healing
  • appropriate periodontal health (measured through periodontal indexes)
  • presence of premolars with indications of extractions, presence of adjacent teeth
  • absence of fenestrations
  • presence of vestibular alveolar wall with a minimum of 0.5mm of thickness

Who cannot join

  • patients who have undergone CT scanning in the past 5 years
  • heavy smokers (more than 20 cigarettes per day)
  • patients not showing up at 1 and 3 months hygiene sessions
  • patients not showing up at 6 months follow-up

About this study

Official title: Evaluation of Morphological and Dimensional Alveolar Bone Changes Around Post-extraction Implants in an Open Flap, Open Flap and Grafting and Flapless Technique. A Clinical Randomized Controlled Study

This is a three-armed randomized controlled clinical trial aiming the estimation of dimensional alveolar bone changes after insertion of post-extraction implants through 3 different surgical techniques: open flap, open flap and grafting, flapless.

Read the detailed description

Background and Objectives A recent systematic review investigating dimensional alveolar bone changes after insertion of post-extraction implants reported that there is a lack of randomized controlled trials that would serve as a scientific base for building clinical guidelines on alveolar site treatment after insertion of post-extraction implants. Different studies suggest that insertion of post-extraction implants should be performed after fully elevating a flap and inserting bone graft in the residual space between the implant surface and the alveolar socket. Other investigations report insignificant differences between open flap and flapless approaches, whereas the insertion of bone grafts remains controversial.

The present study is a three-armed randomized clinical controlled trial conducted with the following objectives:

  1. Evaluation of morphological and alveolar bone level differences (marginal bone loss) on post-extraction implants inserted with the following techniques: 1) open flap surgery alone; 2) open flap surgery and bone grafting; 3) flapless.
  2. Estimation of effectiveness of the three surgical techniques through measurement of secondary outcomes such as intra-operatory and post-operatory complications, pain and discomfort, time and costs.

Materials and Methods

  • This is a three-armed randomized controlled clinical trial where each arm will belong to one of the treatments: 1) open flap surgery alone; 2) open flap surgery and bone grafting; 3) flapless.
  • The randomizing sequence will be generated from a computer program (STATA 13) by a statistician who will also conduct blind statistical analysis of results.
  • All patients will be recruited prior to trial commencement. They will be extensively informed regarding the intervention and will sign a treatment consent.
  • Patients will be recruited according to the following inclusion criteria: absence of any systemic disease that might compromise implant integration or wound healing, appropriate periodontal health (measured through periodontal indexes), presence of premolars with indications of extractions, presence of adjacent teeth, absence of fenestrations, presence of vestibular alveolar wall with a minimum of 0.5mm of thickness. Patients who have undergone CT scanning in the past 5 years and heavy smokers (more than 20 cigarettes per day) will not be included in the study.
  • Calculation of sample size has already been performed by an experienced statistician, accounting for a minimal predicted difference between groups of 1mm (SD 0.75mm) of marginal bone loss, alpha error of 0.05 and 90% of power. Based on these calculations, a total of 45 patients will be included in the study.
  • Interventions will be performed in accordance with ethical standards as suggested by the Helsinki Declaration (1975). Approval of Ethical Committee of the University of Bari has already been obtained (reg.nr. 4987).
  • All surgical interventions will be performed by the same experienced surgeon who will be informed of the type of intervention after tooth extraction (allocation concealment through dark sealed envelopes).
  • The primary outcome is marginal bone loss (MBL) and alveolar bone dimensional changes measured through CT Cone Beam performed immediately after implant insertion and 6 months after. Secondary outcomes are intra-and post-operative complications, pain and discomfort, time and costs.
  • Outcomes will be measured by another clinician blinded in terms of treatment allocation.
  • Statistical analysis will be performed by an independent statistician. Statistical tests will include: One-way Anova, Bonferroni tests and several linear and logistic regressions in order to estimate potential predictive variables. Statistical significance will be set at .05.
  • Interruption of study will be considered in the following situations: 1.preliminary observation of highly significant difference between techniques indicating one technique highly superior; 2. big number of lost to follow-up (bigger than that considered during sample size calculation)
  • Patients will be excluded from the study in the following cases: missing follow-up hygiene controls at 1 and 3 months post-intervention, missing 6 months follow-up control, poor cooperation in terms of domestic oral hygiene (periodontal indexes measured), income of systemic or local diseases that might compromise outcomes.
Being tested
Open flap immediate implant, Open flap immediate implant and bone grafting, Flapless immediate implant
Keywords
post-extraction dental implant, immediate dental implant, open flap, flapless, bone grafting, CT Cone Beam

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Open flap immediate implantDevice

    Also called Dental implant

    Post-extraction implants will be inserted through open flap, without bone grafting

  • Open flap immediate implant and bone graftingDevice

    Also called Dental implant, bone grafting

    Post-extraction implants will be inserted through open flap, adding bone grafting

  • Flapless immediate implantDevice

    Post-extraction implants will be inserted without elevating flap or inserting bone grafting

Study groups in NCT03001752
Study groupRoleWhat they receive
Open flap immediate implantActive comparatorOpen flap immediate implant insertion, without bone grafting
Receives: Device: Open flap immediate implant
Open flap immediate implant and bone graftingActive comparatorOpen flap immediate implant insertion and bone grafting
Receives: Device: Open flap immediate implant and bone grafting
Flapless immediate implantActive comparatorImmediate implant insertion without opening flap of inserting bone grafting
Receives: Device: Flapless immediate implant

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Marginal Bone Loss measured through CT Cone Beam

    Difference of marginal bone level measured immediately after treatment and 6 months after on two repeated (immediately after and 6 months after implant insertion) CT Cone Beam

    Measured: 6 months

  2. Alveolar Bone Dimensional Reduction assessed through CT Cone Beam

    Three-dimensional Alveolar Bone Reduction (horizontal and vertical) will be measured on two repeated (immediately after and 6 months after implant insertion) on CT Cone Beam, having as reference points the implant platform and the implant apex.

    Measured: 6 months

Secondary outcomes (3)
  1. Pain and Discomfort measured through questionaire

    Pain and discomfort experienced by the patient after the surgery, measured through a VAS scale on a questionaire

    Measured: 1 Week

  2. Intra-operatory or post-operatory complications assessed through intra-operatory observation and post-intervention check-ups.

    Intra-operatory or post-operatory intervention-related adverse events such as excessive bleeding, swallowing, hematoma will be recorded for each patient.

    Measured: 6 months

  3. Time needed to perform surgical intervention

    Time needed to perform surgical intervention (immediately after tooth extraction until finishing of surgical procedure) will be recorded for each intervention.

    Measured: 1-2 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Dec 2016 (estimated)
  2. Study startJan 2017
  3. Primary completionAug 2018
  4. Study completionNov 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
45 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03001752
Sponsor's protocol ID
4987
Acronym
ETPEI-RCT
Status last verified
Jan 2019
First submitted
16 Dec 2016
Last updated
17 Jan 2019
Results posted
No
Data monitoring committee
Yes

Publications

  • Lee CT, Chiu TS, Chuang SK, Tarnow D, Stoupel J. Alterations of the bone dimension following immediate implant placement into extraction socket: systematic review and meta-analysis. J Clin Periodontol. 2014 Sep;41(9):914-26. doi: 10.1111/jcpe.12276. Epub 2014 Jul 23.

    PubMed 24894299
  • Tarnow DP, Chu SJ. Human histologic verification of osseointegration of an immediate implant placed into a fresh extraction socket with excessive gap distance without primary flap closure, graft, or membrane: a case report. Int J Periodontics Restorative Dent. 2011 Sep-Oct;31(5):515-21.

    PubMed 21845246

Questions about this trial

What is this clinical trial studying?

A study testing Open flap immediate implant, Open flap immediate implant and bone grafting and Flapless immediate implant in people with Isolated Premolar Edentulous Site, run by University of Bari.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Jan 2019. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Marginal Bone Loss measured through CT Cone Beam (time frame: 6 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03001752, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jan 2019.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in